What is the current Healthcare CDMO Market size?

The Healthcare CDMO Market is projected to register a CAGR of 8.20% during the forecast period (2024-2029) Read More

Who are the key players in Healthcare CDMO Market?

Catalent Inc., Lonza, Recipharm AB, Thermo Fisher Scientific, Inc and Labcorp Drug Development are the major companies operating in the Healthcare CDMO Market. Read More

Which is the fastest growing region in Healthcare CDMO Market?

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Healthcare CDMO Market?

In 2024, the Asia Pacific accounts for the largest market share in Healthcare CDMO Market. Read More

What years does this Healthcare CDMO Market cover?

The report covers the Healthcare CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Healthcare CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Healthcare CDMO Market Share

Statistics for the 2023 & 2024 Healthcare CDMO market share, created by Mordor Intelligence™ Industry Reports. Healthcare CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Healthcare CDMO Industry

The healthcare contract development and manufacturing organization market is fragmented in nature, with the presence of many market players anticipated to concentrate on offering one-stop-shop services to gain a competitive edge. Moreover, market players are engaging in strategic activities such as service expansion, collaboration, partnerships, and mergers and acquisitions.

Some of the key players in the healthcare CDMO market are Catalent Inc., Lonza, Recipharm AB, Thermo Fisher Scientific, Inc., Labcorp Drug Development, and IQVIA Inc.